MICS, an easily ignored contributor to arterial calcification in CKD patients

American Journal of Physiology - Renal Physiology

Volumn 311, Issue 4, 2016, Pages F663-F670

  Zhang, Kun ^a,b   Gao, Jingwei ^a,b   Chen, Jie ^a,b   Liu, Xun ^c   Cai, Qingqing ^d   Liu, Pinming ^a,b   Huang, Hui ^a,b  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Arterial calcification; Chronic kidney disease; Chronic kidney disease mineral bone disorder; Malnutrition inflammation complex syndrome; Vascular smooth muscle cells

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; C REACTIVE PROTEIN; FETUIN A; FIBROBLAST GROWTH FACTOR 23; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; OSTEOCALCIN; OSTEOPONTIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR; VITAMIN K GROUP;

ARTERY CALCIFICATION; BODY MASS; BONE DEVELOPMENT; CARDIOVASCULAR MORTALITY; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; END STAGE RENAL DISEASE; HUMAN; MALNUTRITION; MALNUTRITION INFLAMMATION COMPLEX SYNDROME; NONHUMAN; OBESITY; OSTEOLYSIS; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; REVIEW; RISK FACTOR; VASCULAR SMOOTH MUSCLE CELL; VITAMIN K DEFICIENCY; CHRONIC KIDNEY FAILURE; COMPLICATION; INFLAMMATION; SYNDROME; VASCULAR CALCIFICATION;

HUMANS; INFLAMMATION; MALNUTRITION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SYNDROME; VASCULAR CALCIFICATION;

EID: 84989907269     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00189.2016     Document Type: Review

References (110)

1. Abedin M, Lim J, Tang TB, Park D, Demer LL, Tintut Y. N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. Circ Res 98: 727-729, 2006.
2. Agharazii M, St-Louis R, Gautier-Bastien A, Ung RV, Mokas S, Lariviere R, Richard DE. Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification. Am J Hypertens 28: 746-755, 2015.
3. Al-Aly Z. Medial vascular calcification in diabetes mellitus and chronic kidney disease: the role of inflammation. Cardiovasc Hematol Disord Drug Targets 7: 1-6, 2007.
4. Al-Dadah A, Omran J, Nusair MB, Dellsperger KC. Cardiovascular mortality in dialysis patients. Adv Perit Dial 28: 56-59, 2012.
5. An WS, Lee SM, Son YK, Kim SE, Kim KH, Han JY, Bae HR, Rha SH, Park Y. Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients. Nutr Res 32: 495-502, 2012.
6. Anand N, Chandrasekaran SC, Alam MN. The malnutrition inflammation complex syndrome-the “MICS-ing” factor in the perio-chronic kidney disease interlink. J Clin Diagn Res 7: 763-767, 2013.
7. Andress DL. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 69: 33-43, 2006.
8. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942, 2001.
9. Caglar K, Hakim RM, Ikizler TA. Approaches to the reversal of malnutrition, inflammation, and atherosclerosis in end-stage renal disease. Nutr Rev 60: 378-387, 2002.
10. Canepa M, Ameri P, AlGhatrif M, Pestelli G, Milaneschi Y, Strait JB, Giallauria F, Ghigliotti G, Brunelli C, Lakatta EG, Ferrucci L. Role of bone mineral density in the inverse relationship between body size and aortic calcification: results from the Baltimore Longitudinal Study of Aging. Atherosclerosis 235: 169-175, 2014.
11. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, Mitch WE, Price SR, Wanner C, Wang AY, ter Wee P, Franch HA. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr 23: 77-90, 2013.
12. Checherita IA, Smarandache D, David C, Ciocalteu A, Ion DA, Lascar I. Vascular calcifications in chronic kidney diseaseclinical management. Rom J Morphol Embryol 53: 7-13, 2012.
13. Chen J, Peng H, Xiao L, Zhang K, Yuan Z, Chen J, Wang Z, Wang J, Huang H. Inflammation but not dietary macronutrients insufficiency associated with the malnutrition-inflammation score in hemodialysis population. PloS one 8: e83233, 2013.
14. Chen J, Peng H, Yuan Z, Zhang K, Xiao L, Huang J, Wang J, Huang H. Combination with anthropometric measurements and MQSGA toassess nutritional status in Chinese hemodialysis population. Int J Med Sci 10: 974-980, 2013.
15. Chen J, Peng H, Zhang K, Xiao L, Yuan Z, Wang Z, Wang J, Huang H. The insufficiency intake of dietary micronutrients associated with malnutrition-inflammation score in hemodialysis population. PLoS One 8: e66841, 2013.
16. Chen NX, Moe SM. Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep 14: 228-237, 2012.
17. Chmielewski M, Verduijn M, Drechsler C, Lindholm B, Stenvinkel P, Rutkowski B, Boeschoten EW, Krediet RT, Dekker FW. Low cholesterol in dialysis patients-causal factor for mortality or an effect of confounding? Nephrol Dial Transplant 26: 3325-3331, 2011.
18. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske BL, Kutner N, Liu J, St Peter W, Guo H, Hu Y, Kats A, Li S, Li S, Maloney J, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Johnson R, Sheets D, Wang X, Forrest B, Berrini D, Constantini E, Everson S, Eggers P, Agodoa L. US Renal Data System 2013 Annual Data Report. Am J Kidney Dis 63: A7, 2014.
19. Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 68: 429-436, 2005.
20. Dautova Y, Kozlova D, Skepper JN, Epple M, Bootman MD, Proudfoot D. Fetuin-A and albumin alter cytotoxic effects of calcium phosphate nanoparticles on human vascular smooth muscle cells. PLoS One 9: e97565, 2014.
21. Demer L, Tintut Y. The bone-vascular axis in chronic kidney disease. Curr Opin Nephrol Hypertens 19: 349-353, 2010.
22. Dukkipati R, Kovesdy CP, Colman S, Budoff MJ, Nissenson AR, Sprague SM, Kopple JD, Kalantar-Zadeh K. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr 20: 243-254, 2010.
23. Dzekova P, Nikolov IG, Sikole A, Grozdanovski R, Polenakovic MH. Malnutrition inflammation complex syndrome in maintenance haemodialysis patients. Prilozi 26: 61-69, 2005.
24. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevino-Becerra A, Wanner C. A proposed nomenclature and diagnostic criteria for proteinenergy wasting in acute and chronic kidney disease. Kidney Int 73: 391-398, 2008.
25. Geng Y, Hsu JJ, Lu J, Ting TC, Miyazaki M, Demer LL, Tintut Y. Role of cellular cholesterol metabolism in vascular cell calcification. J Biol Chem 286: 33701-33706, 2011.
26. Goodman WG. Vascular calcification in end-stage renal disease. J Nephrol 15, Suppl 6: S82-S85, 2002.
27. Gutierrez OM, Wolf M. Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies. Semin Dial 23: 401-406, 2010.
28. Haddad M, Tajbakhsh R, Farajollahi M, Qorbani M, Besharat S, Joshaghani HR. Association of serum fetuin-A and biochemical parameters in hemodialysis patients. Saudi J Kidney Dis Transpl 25: 769-773, 2014.
29. Han X, Li L, Yang J, King G, Xiao Z, Quarles LD. Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages. FEBS Lett 590: 53-67, 2016.
30. Hjortnaes J, Butcher J, Figueiredo JL, Riccio M, Kohler RH, Kozloff KM, Weissleder R, Aikawa E. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J 31: 1975-1984, 2010.
31. Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, Moe OW. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22: 124-136, 2010.
32. Impellizzeri D, Esposito E, Attley J, Cuzzocrea S. Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD). Pharmacol Res 81: 91-102, 2014.
33. Ishimura E, Okuno S, Kitatani K, Tsuchida T, Yamakawa T, Shioi A, Inaba M, Nishizawa Y. Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol 68: 222-227, 2007.
34. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99: 1044-1059, 2006.
35. Kaesler N, Magdeleyns E, Herfs M, Schettgen T, Brandenburg V, Fliser D, Vermeer C, Floege J, Schlieper G, Kruger T. Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation. Kidney Int 86: 286-293, 2014.
36. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63: 793-808, 2003.
37. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42: 864-881, 2003.
38. Kalantar-Zadeh K, Kopple JD. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38: 1343-1350, 2001.
39. Kalantar-Zadeh K, Kopple JD. Trace elements and vitamins in maintenance dialysis patients. Adv Ren Replace Ther 10: 170-182, 2003.
40. Kalantar-Zadeh K, Kopple JD, Deepak S, Block D, Block G. Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr 12: 17-31, 2002.
41. Kanbay M, Goldsmith D, Uyar ME, Turgut F, Covic A. Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif 29: 280-292, 2010.
42. Kaysen GA, Chertow GM, Adhikarla R, Young B, Ronco C, Levin NW. Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 60: 333-340, 2001.
43. Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, SmitsG, Chonchol M, HOST (Homocysteinemia in Kidney and End Stage Renal Disease) Study Investigators. FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 22: 1913-1922, 2011.
44. Kircelli F, Peter ME, Sevinc Ok E, Celenk FG, Yilmaz M, Steppan S, Asci G, Ok E, Passlick-Deetjen J. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 27: 514-521, 2012.
45. Kiu Weber CI, Duchateau-Nguyen G, Solier C, Schell-Steven A, Hermosilla R, Nogoceke E, Block G. Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4. Clin Kidney J 7: 167-173, 2014.
46. Kopple J. Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J 43: 246-250, 1997.
47. Kovacic JC, Lee P, Baber U, Karajgikar R, Evrard SM, Moreno P, Mehran R, Fuster V, Dangas G, Sharma SK, Kini AS. Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. Atherosclerosis 221: 176-182, 2012.
48. Kovesdy CP, Kalantar-Zadeh K. Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol 29: 3-14, 2009.
49. Kovesdy CP, Kopple JD, Kalantar-Zadeh K. Management of proteinenergy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr 97: 1163-1177, 2013.
50. Lau WL, Leaf EM, Hu MC, Takeno MM, Kuro-o M, Moe OW, Giachelli CM. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int 82: 1261-1270, 2012.
51. Lee SM, An WS. Cardioprotective effects of omega -3 PUFAs in chronic kidney disease. Biomed Res Int 2013: 712949, 2013.
52. Lemos MM, Watanabe R, Carvalho AB, Jancikic AD, Sanches FM, Christofalo DM, Draibe SA, Canziani ME. Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study. Clin Nephrol 80: 1-8, 2013.
53. Leopold JA. Vascular calcification: Mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med 25: 267-274, 2015.
54. Lim K, Lu TS, Molostvov G, Lee C, Lam FT, Zehnder D, Hsiao LL. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 125: 2243-2255, 2012.
55. Liu H, Li X, Qin F, Huang K. Selenium suppresses oxidative-stressenhanced vascular smooth muscle cell calcification by inhibiting theactivation of the PI3K/AKT and ERK signaling pathways and endoplasmic reticulum stress. J Biol Inorg Chem 19: 375-388, 2014.
56. Liu J, Ma KL, Gao M, Wang CX, Ni J, Zhang Y, Zhang XL, Liu H, Wang YL, Liu BC. Inflammation disrupts the LDL receptor pathway and accelerates the progression of vascular calcification in ESRD patients. PLoS One 7: e47217, 2012.
57. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ. Association between cholesterol level and mortality in dialysis patients_ role of inflammation and malnutrition. JAMA 291: 451-459, 2004.
58. London GM. Bone-vascular axis in chronic kidney disease: a reality? Clin J Am Soc Nephrol 4: 254-257, 2009.
59. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740, 2003.
60. Lu KC, Wu CC, Yen JF, Liu WC. Vascular calcification and renal bone disorders. Sci World J 2014: 637065, 2014.
61. Maekawa Y, Ishikawa K, Yasuda O, Oguro R, Hanasaki H, Kida I, Takemura Y, Ohishi M, Katsuya T, Rakugi H. Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine 35: 341-346, 2009.
62. Massy ZA, Drueke TB. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J 5: i52-i61, 2012.
63. Massy ZA, Maziere C, Kamel S, Brazier M, Choukroun G, Tribouilloy C, Slama M, Andrejak M, Maziere JC. Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease. Pediatr Nephrol 20: 380-382, 2005.
64. Matsubara K, Stenvinkel P, Qureshi AR, Carrero JJ, Axelsson J, Heimburger O, Barany P, Alvestrand A, Lindholm B, Suliman ME. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. J Nephrol 22: 774-782, 2009.
65. McCabe KM, Booth SL, Fu X, Shobeiri N, Pang JJ, Adams MA, Holden RM. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int 83: 835-844, 2013.
66. McCarthy DO. Tumor necrosis factor alpha and interleukin-6 have differential effects on food intake and gastric emptying in fasted rats. Res Nurs Health 23: 222-228, 2000.
67. Mesquita M, Demulder A, Damry N, Melot C, Wittersheim E, Willems D, Dratwa M, Bergmann P. Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. Clin Chem Lab Med 47: 339-346, 2009.
68. Mitch WE, Maroni BJ. Factors causing malnutrition in patients with chronic uremia. Am J Kidney Dis 33: 176-179, 1999.
69. Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 20: 1453-1464, 2009.
70. Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V, van Leeuwen FN, Touyz RM. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 56: 453-462, 2010.
71. Moody WE, Edwards NC, Madhani M, Chue CD, Steeds RP, Ferro CJ, Townend JN. Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association? Atherosclerosis 223: 86-94, 2012.
72. Morena M, Dupuy AM, Jaussent I, Vernhet H, Gahide G, Klouche K, Bargnoux AS, Delcourt C, Canaud B, Cristol JP. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. Nephrol Dial Transplant 24: 3389-3397, 2009.
73. Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol 4: 1892-1900, 2009.
74. Nascimento MM, Hayashi SY, Riella MC, Lindholm B. Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease. Brazilian J Med Biol Res 47: 995-1002, 2014.
75. Nasrallah MM, El-Shehaby AR, Osman NA, Fayad T, Nassef A, Salem MM, Sharaf El Din UA. The association between fibroblastgrowth factor-23 and vascular calcification Is mitigated by inflammation markers. Nephron Extra 3: 106-112, 2013.
76. Nicoll R, Howard JM, Henein MY. A review of the effect of diet on cardiovascular calcification. Int J Mol Sci 16: 8861-8883, 2015.
77. Nitta K, Ogawa T. Vascular calcification in end-stage renal disease patients. Contrib Nephrol 185: 156-167, 2015.
78. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106: 100-105, 2002.
79. Ojo A. Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc 125: 229-246, 2014.
80. Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F, Massy ZA, Rossignol P, Vanholder R, Wiecek A, Zoccali C, London GM. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet 383: 1831-1843, 2014.
81. Paloian NJ, Giachelli CM. A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol 307: F891-F900, 2014.
82. Park J, Ahmadi SF, Streja E, Molnar MZ, Flegal KM, Gillen D, Kovesdy CP, Kalantar-Zadeh K. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis 56: 415-425, 2014.
83. Park JS, Choi UJ, Lim HS, Choi BJ, Choi SY, Yoon MH, Hwang GS, Tahk SJ, Shin JH. The relationship between coronary artery calcification as assessed by multi-detector computed tomography and arterial stiffness. Clin Exp Hypertens 33: 501-505, 2011.
84. Peralta-Ramirez A, Montes de Oca A, Raya AI, Pineda C, Lopez I, Guerrero F, Diez E, Munoz-Castaneda JR, Martinez J, Almaden Y, Rodriguez M, Aguilera-Tejero E. Vitamin E protection of obesityenhanced vascular calcification in uremic rats. Am J Physiol Renal Physiol 306: F422-F429, 2014.
85. Price PA, Roublick AM, Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 70: 1577-1583, 2006.
86. Rodriguez-Garcia M, Gomez-Alonso C, Naves-Diaz M, Diaz-Lopez JB, Diaz-Corte C, Cannata-Andia JB; Asturias Study Group. Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol Dial Transplant 24: 239-246, 2009.
87. Schlieper G, Schurgers L, Brandenburg V, Reutelingsperger C, Floege J. Vascular calcification in chronic kidney disease: an update. Nephrol Dialysis Transplant 31: 31-39, 2016.
88. Schmidt N, Brandsch C, Kuhne H, Thiele A, Hirche F, Stangl GI. Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLoS One 7: e35316, 2012.
89. Schmidt N, Brandsch C, Schutkowski A, Hirche F, Stangl GI. Dietary vitamin D inadequacy accelerates calcification and osteoblast-like cell formation in the vascular system of LDL receptor knockout and wildtype mice. J Nutr 144: 638-646, 2014.
90. Schurgers LJ, Spronk HM, Skepper JN, Hackeng TM, Shanahan CM, Vermeer C, Weissberg PL, Proudfoot D. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 5: 2503-2511, 2007.
91. Seiler S, Rogacev KS, Roth HJ, Shafein P, Emrich I, Neuhaus S, Floege J, Fliser D, Heine GH. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4. Clin J Am Soc Nephrol 9: 1049-1058, 2014.
92. Sigrist M, Bungay P, Taal MW, McIntyre CW. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 21: 707-714, 2006.
93. Smith ER, Ford ML, Tomlinson LA, Bodenham E, McMahon LP, Farese S, Rajkumar C, Holt SG, Pasch A. Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol 25: 339-348, 2014.
94. Spiegel DM, Farmer B. Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: a pilot study. Hemodial Int 13: 453-459, 2009.
95. Srivaths PR, Silverstein DM, Leung J, Krishnamurthy R, Goldstein SL. Malnutrition-inflammation-coronary calcification in pediatric patients receiving chronic hemodialysis. Hemodial Int 14: 263-269, 2010.
96. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O’Grady NP. New insights into the biology of the acute phase response. J Clin Immunol 19: 203-214, 1999.
97. Takx RA, MacNabb MH, Emami H, Abdelbaky A, Singh P, Lavender ZR, di Carli M, Taqueti V, Foster C, Mann J, Comley RA, Weber CI, Tawakol A. Increased arterial inflammation in individuals with stage 3 chronic kidney disease. Eur J Nucl Med Mol Imaging 2015 Oct 14. [Epub ahead of print].
98. Tenenbaum A, Shemesh J, Koren-Morag N, Fisman EZ, Adler Y, Goldenberg I, Tanne D, Hay I, Schwammenthal E, Motro M. Longterm changes in serum cholesterol level does not influence the progression of coronary calcification. Int J Cardiol 150: 130-134, 2011.
99. Turner AG, Hanrath MA, Morris HA, Atkins GJ, Anderson PH. The local production of 1,25(OH)2D3 promotes osteoblast and osteocyte maturation. J Steroid Biochem Mol Biol 144A: 114-118, 2014.
100. Viaene L, Behets GJ, Heye S, Claes K, Monbaliu D, Pirenne J, D’Haese PC, Evenepoel P. Inflammation and the bone-vascular axis in end-stage renal disease. Osteoporos Int 27: 489-497, 2016.
101. Wang AY, Lam CW, Wang M, Chan IH, Yu CM, Lui SF, Sanderson JE. Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease: a prospective cohort study. Am J Nephrol 28: 647-653, 2008.
102. Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12: 1927-1936, 2001.
103. Westenfeld R, Jahnen-Dechent W, Ketteler M. Vascular calcification and fetuin-A deficiency in chronic kidney disease. Trends Cardiovasc Med 17: 124-128, 2007.
104. Westenfeld R, Krueger T, Schlieper G, Cranenburg EC, Magdeleyns EJ, Heidenreich S, Holzmann S, Vermeer C, Jahnen-Dechent W, Ketteler M, Floege J, Schurgers LJ. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 59: 186-195, 2012.
105. Yamada S, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, Masutani K, Ooboshi H, Tsuruya K, Kitazono T. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. Am J Physiol Renal Physiol 306: F1418-F1428, 2014.
106. Yamada S, Tokumoto M, Tatsumoto N, Tsuruya K, Kitazono T, Ooboshi H. Very low protein diet enhances inflammation, malnutrition, and vascular calcification in uremic rats. Life Sci 146: 117-123, 2016.
107. Yamada S, Tokumoto M, Tsuruya K, Tatsumoto N, Noguchi H, Kitazono T, Ooboshi H. Fetuin-A decrease induced by a low protein diet enhances vascular calcification in uremic rats with hyperphosphatemia. Am J Physiol Renal Physiol 309: F744-F754, 2015.
108. Yigit IP, Celiker H, Dogukan A, Ilhan N, Gurel A, Ulu R, Aygen B. Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter? Ren Fail 37: 77-82, 2015.
109. Zapolski T. Malnutrition-inflammation complex syndrome: link between end-stage renal disease, atherosclerosis and valvular calcification. Hypertens Res 33: 541-543, 2010.
110. Zhang K, Cheng G, Cai X, Chen J, Jiang Y, Wang T, Wang JF, Huang H. Malnutrition, a new inducer for arterial calcification in hemodialysis patients? J Transl Med 11: 66, 2013.